159 related articles for article (PubMed ID: 10346934)
21. Inhibition of proliferation of human leukaemia 60 cells by diethyl esters of glyoxalase inhibitors in vitro.
Lo TW; Thornalley PJ
Biochem Pharmacol; 1992 Dec; 44(12):2357-63. PubMed ID: 1472100
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxic evaluation of some N-acyl and N-acyloxy analogues of 3,5-bis(arylidene)-4-piperidones.
Dimmock JR; Arora VK; Chen M; Allen TM; Kao GY
Drug Des Discov; 1994 Jul; 12(1):19-28. PubMed ID: 7578805
[TBL] [Abstract][Full Text] [Related]
23. Maillard reactions in lens proteins: methylglyoxal-mediated modifications in the rat lens.
Shamsi FA; Sharkey E; Creighton D; Nagaraj RH
Exp Eye Res; 2000 Mar; 70(3):369-80. PubMed ID: 10712823
[TBL] [Abstract][Full Text] [Related]
24. Effects of flavonoids on glutathione and glutathione-related enzymes in cisplatin-treated L1210 leukemia cells.
Cipák L; Berczeliová E; Paulíková H
Neoplasma; 2003; 50(6):443-6. PubMed ID: 14689067
[TBL] [Abstract][Full Text] [Related]
25. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
26. Proapoptotic activity of new glutathione S-transferase inhibitors.
Turella P; Cerella C; Filomeni G; Bullo A; De Maria F; Ghibelli L; Ciriolo MR; Cianfriglia M; Mattei M; Federici G; Ricci G; Caccuri AM
Cancer Res; 2005 May; 65(9):3751-61. PubMed ID: 15867371
[TBL] [Abstract][Full Text] [Related]
27. Glyoxalase II in Saccharomyces cerevisiae: in situ kinetics using the 5,5'-dithiobis(2-nitrobenzoic acid) assay.
Martins AM; Cordeiro C; Freire AP
Arch Biochem Biophys; 1999 Jun; 366(1):15-20. PubMed ID: 10334858
[TBL] [Abstract][Full Text] [Related]
28. Novel fluorinated prodrugs for activation by carboxypeptidase G2 showing good in vivo antitumor activity in gene-directed enzyme prodrug therapy.
Davies LC; Friedlos F; Hedley D; Martin J; Ogilvie LM; Scanlon IJ; Springer CJ
J Med Chem; 2005 Aug; 48(16):5321-8. PubMed ID: 16078849
[TBL] [Abstract][Full Text] [Related]
29. Anti-tumor effect of N-beta-alanyl-5-S-glutathionyldihydroxyphenylalanine (5-S-GAD), a novel anti-bacterial substance from an insect.
Akiyama N; Hijikata M; Kobayashi A; Yamori T; Tsuruo T; Natori S
Anticancer Res; 2000; 20(1A):357-62. PubMed ID: 10769680
[TBL] [Abstract][Full Text] [Related]
30. Further studies on liver glyoxalase I and glyoxalase II. Activity in mice bearing sarcoma 180 and L1210 leukemia.
Winter R; Piskorska D; Jerzykowski T
Neoplasma; 1978; 25(4):465-70. PubMed ID: 692805
[TBL] [Abstract][Full Text] [Related]
31. Enzymatic and nonenzymatic synthesis of glutathione conjugates: application to the understanding of a parasite's defense system and alternative to the discovery of potent glutathione S-transferase inhibitors.
Lo WJ; Chiou YC; Hsu YT; Lam WS; Chang MY; Jao SC; Li WS
Bioconjug Chem; 2007; 18(1):109-20. PubMed ID: 17226963
[TBL] [Abstract][Full Text] [Related]
32. CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors.
Pan C; Cardarelli PM; Nieder MH; Pickford LB; Gangwar S; King DJ; Yarranton GT; Buckman D; Roscoe W; Zhou F; Salles A; Chen TH; Horgan K; Wang YH; Nguyen T; Bebbington CR
Cancer Res; 2003 Sep; 63(17):5526-31. PubMed ID: 14500390
[TBL] [Abstract][Full Text] [Related]
33. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
[TBL] [Abstract][Full Text] [Related]
34. [Antisense oligonucleotides with antitumor activity].
Otvös L; Sági G
Magy Onkol; 2004; 48(3):221-7. PubMed ID: 15520872
[TBL] [Abstract][Full Text] [Related]
35. Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU.
Rice KP; Penketh PG; Shyam K; Sartorelli AC
Biochem Pharmacol; 2005 May; 69(10):1463-72. PubMed ID: 15857610
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of mammalian glyoxalase I (lactoylglutathione lyase) by N-acylated S-blocked glutathione derivatives as a probe for the role of the N-site of glutathione in glyoxalase I mechanism.
Al-Timari A; Douglas KT
Biochim Biophys Acta; 1986 Mar; 870(1):160-8. PubMed ID: 3947646
[TBL] [Abstract][Full Text] [Related]
37. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity.
Komatsu Y; Tomizaki KY; Tsukamoto M; Kato T; Nishino N; Sato S; Yamori T; Tsuruo T; Furumai R; Yoshida M; Horinouchi S; Hayashi H
Cancer Res; 2001 Jun; 61(11):4459-66. PubMed ID: 11389076
[TBL] [Abstract][Full Text] [Related]
38. Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate.
Cacciatore I; Caccuri AM; Cocco A; De Maria F; Di Stefano A; Luisi G; Pinnen F; Ricci G; Sozio P; Turella P
Amino Acids; 2005 Nov; 29(3):255-61. PubMed ID: 16082503
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity of rhenium(I) alkoxo and hydroxo carbonyl complexes in murine and human tumor cells.
Yan YK; Cho SE; Shaffer KA; Rowell JE; Barnes BJ; Hall IH
Pharmazie; 2000 Apr; 55(4):307-13. PubMed ID: 10798247
[TBL] [Abstract][Full Text] [Related]
40. The human glutathione transferase P1-1 specific inhibitor TER 117 designed for overcoming cytostatic-drug resistance is also a strong inhibitor of glyoxalase I.
Johansson AS; Ridderström M; Mannervik B
Mol Pharmacol; 2000 Mar; 57(3):619-24. PubMed ID: 10692504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
